{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"XBCVnE7DmA\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/\">IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/imagin-medical-reports-manufacturing-progess\/embed\/#?secret=XBCVnE7DmA\" width=\"600\" height=\"338\" title=\"&#8220;IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS&#8221; &#8212; Market Newsdesk\" data-secret=\"XBCVnE7DmA\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"VANCOUVER, B.C. \/ BOSTON, March 16, 2021 (GLOBE NEWSWIRE) &#8212; via InvestorWire \u2013 Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt &amp; Stuttgart Symbol: DPD2) (\u201cImagin\u201d or the \u201cCompany\u201d) today reported continued progress towards commercial-stage manufacturing capability with Lighthouse Imaging (\u201cLighthouse\u201d). Prior to Imagin\u2019s selection of Lighthouse as its contract manufacturer for the i\/Blue Imaging System\u2122 in October 2020, the Company received multiple fully functional feasibility units from its original design partner, Optel, Inc. Lighthouse\u2019s development program has since focused on further refining the design to support Imagin\u2019s submissions to the U.S. Food and Drug Administration and to ensure final device performance, compliance with all applicable regulatory standards, and optimal manufacturability to meet both cost targets and anticipated user demand. &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg0NyM0MDYzNzQ3IzUwMDA3Njk1NQ=="}